SCHEMBL15323632

SCHEMBL15323632

NC(=O)COc1ccc2c(c1)C(Cc1cccc(Cl)c1)C(N1CCCC1)CC2

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 13/20 0.49
KCNH2 Q12809 4/20 0.49
HTT P42858 1/20 0.43
ENPP2 Q13822 1/20 0.40
SIGMAR1 Q99720 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3099040 0.99 SLC6A9 (0.49) SLC6A9KCNH2HTTENPP2SIGMAR1
SCHEMBL15324310 0.98 SLC6A9 (0.51) SLC6A9KCNH2HTTENPP2
Hydrochloric Acid SCHEMBL3108920 0.97 SLC6A9 (0.51) SLC6A9KCNH2HTTENPP2
SCHEMBL15323756 0.88 SLC6A9 (0.51) SLC6A9KCNH2SIGMAR1
SCHEMBL3105644 0.88 SLC6A9 (0.62) SLC6A9KCNH2SIGMAR1
SCHEMBL3109101 0.88 SLC6A9 (0.51) SLC6A9KCNH2
Hydrochloric Acid SCHEMBL3099007 0.88 SLC6A9 (0.50) SLC6A9KCNH2SIGMAR1
Hydrochloric Acid SCHEMBL3108657 0.87 SLC6A9 (0.61) SLC6A9KCNH2SIGMAR1
SCHEMBL3094433 0.87 SLC6A9 (0.56) SLC6A9HTTENPP2
SCHEMBL15323634 0.86 SLC6A9 (0.53) SLC6A9KCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396296-B1 AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND (DE) 2016-05-25 EP claimed
US-9067871-B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2015-06-30 US claimed
US-8563617-B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2013-10-22 US claimed